HFSA 2017 Comprehensive Heart Failure Review Papa & Hoʻohou | Nā Papa Video Pilikino.

HFSA 2017 Comprehensive Heart Failure Review Course & Update

mau uku: $15.00
Sale kumukuai: $15.00
mau uku
ʻO ke kumu kūʻai: no ka

HFSA 2017 Comprehensive Heart Failure Review Papa & Hoʻohou

E kiʻi ʻoe i ka link VIA LIFETIME DOWNLOAD LINK (FAST SPEED) MA hope o ka uku

Description:

Hōʻuluʻulu hanana

Makemake mākou e ʻike iā ʻoe i ka 2017 HFSA Nānā Haʻawina ma ʻOkakopa 12-15, 2017 ma ka Scottsdale Marriott ma McDowell Mountains ma Scottsdale, AZ. E ʻoluʻolu e lawe i kahi manawa e loiloi ai i ka ʻike ma lalo e kōkua ai i ka hoʻonui ʻana i kāu ʻike ʻaha kūkā.

hōʻuluʻulu manaʻo

Kūkulu ka 2017 Comprehensive Heart Failure Review Course ma luna o ka HFSA holomua 2015 Review a me ka 2016 Papa Loiloi Papa ma o ka hoʻohui ʻana i nā hopena o nā noiʻi noiʻi hou, e hoʻonui ana i ka nānā ʻana i nā ʻōlelo aʻoaʻo hoʻokele kūpono, e kamaʻilio ana i nā pilikia i loaʻa i ka hana, me ka hoʻohui ʻana i nā hihia hihia, a me ka hāʻawi ʻana i nā hālāwai breakout i nā wahi o hoihoi kūikawā.

Nā Pahuhopu Aʻo

I ka hopena o kēia hana hoʻonaʻauao, hiki i nā mea komo ke:

E wehewehe i ka epidemiology o ka puʻuwai puʻuwai a hoʻokō i nā hoʻolālā no ka pale ʻana i ka maikaʻi ʻole o ka puʻuwai.
E wehewehe i ka pathophysiology o ka holo pono ʻole o ka puʻuwai, e like me ka physiology maʻamau a me nā ʻano hana compensatory a me maladaptive.
Loiloi a alualu i ka mea maʻi me ka hōʻeha a i ʻole ka holomua o ka puʻuwai, e hoʻohana ana i nā hoʻokolohua non-invasive a invasive a me nā biomarkers.
Hoʻokomo i ka lāʻau hoʻomalu e pili ana i ke alakaʻi no nā mea maʻi me ka puʻuwai puʻuwai ʻole, e like me nā mea lāʻau a me nā koho non-pharmacologic, e like me ka meaʻai a me ka hoʻoikaika kino a me nā hāmeʻa implantable.
E noi i nā hoʻolālā mālama kūpono no nā mea maʻi me ka pulmonary hypertension, RV ʻole, ka puʻuwai puʻuwai me ka hapa ejection e mālama ʻia, cardiorenal syndrome, peripartum a me nā myopathies infiltrative.
Mālama i nā comorbidities i nā mea maʻi me ka puʻuwai puʻuwai ʻole, e like me ka hiamoe hiamoe ʻole, anemia, a me ke kaumaha.
Hoʻokomo i nā hoʻolālā no ka mālama pono ʻana i ka maʻi o ka mea maʻi me ka maikaʻi ʻole o ka puʻuwai, e like me ka mālama palliative a me ka hoʻololi ʻana i ka mālama maʻi maʻi.
E wehewehe i nā ʻano o nā moho kūpono no ka loli ʻana o ka naʻau a i ʻole ke kākoʻo uila holo kaʻa.
E noi i nā hoʻolālā no ka hoʻokele arrrialia atrial a me ventricular.
E hoʻomaʻamaʻa pono i ka pōʻaiapili o ka hoʻoponopono olakino olakino a me nā mea pono i hoʻokumu ʻia

+ Kumuhana / Luna Hoomalu:

B1-1 - Nānā i ka mea maʻi me ka HF hoʻomaka hou
B1-2 - Hoʻohana Pono o nā Models Wanana Pilikino
B1-3 - Hiamoe hanu ʻole
B2-1 - Nā paena o nā ʻaʻa Kūʻai o RAAS Inhibition
B2-2 - Hoʻolālā Hemodynamic kiʻekiʻe
B3-1 - Pehea e hoʻonohonoho ai i kahi HF Clinic a me ka Polokalamu Diastolic HF
B3-2 - Pehea e hoʻonohonoho ai i kahi Polokalamu Monitoring Remote
B4-1 - Ke Kūkākūkā - Pehea e hana maʻalahi ai i ke kamaʻilio
B4-2 - Hoʻohana kūpono o Biomarkers i ka hoʻonohonoho Clinical
B4-3 - Nānā Nānā VAD Case
S1-1 - Nā Ke Ana Hoʻohālike a me nā Mīkini o HFrEF a me HFpEF
S1-2 - Hoʻohou i nā Kuhi Hou
S1-3 - ARNI's a me Ivabradine
S1-4 - Nā ʻōnaehana e kū nei no ka HF maʻi
S1-5 - HFpEF Mōʻaukala Kūlohelohe a me ka Hoʻolālā Contemporary
S1-6 - Kūkākūkā Kūlana Hihia
S2-1 - Mōʻaukala Kūlohelohe & Nānā Hoomanawanui
S2-2 - Vasodilators & Inotropes He aha nā mea hou a he aha nā mea e holo nei
S2-3 - Huʻi HF nui, Cardiorenal Syndrome a me Diuretic Resistence
S2-4 - Diuretics i ka poʻe maʻi i hōʻola ʻia i ka halemai i kēia manawa nā Controversialies a me nā Therapies e kū nei
S2-5 - Kūkākūkā Kūlana Hihia
S3-1 - Nānā Hoʻomanaʻo Hoʻomanaʻo
S3-2 - Ke mālama nei iā PAH i ke au o kēia au
S3-3 - Pulmonary Hypertension a me ka HF hema
S3-4 - HF ʻākau
S3-5 - Kūkākūkā Kūlana Hihia
S4-1 - Biomarker 2017 Hoʻohou He aha ka mea wela, he aha ka mea ʻole
S4-2 - Nā Hopena Hemodynamic Invasive a me nā Non-Invasive
S4-3 - Nānā mamao aku i nā Kelepona Kelepona Telehealth
S5-1 - Ke ʻano loli ma waena o INTERMACS Profile I
S5-2 - Hemodynamics o ka Shock Cardiogenic a me nā hāmeʻa
S5-3 - Nā hāmeʻa Percutaneness a me ECMO
S5-4 - Q&A
S6-1 - Ke wehewehe nei i ka holomua HF
S6-2 - Ke koho maʻi maʻi maʻi transplant
S6-3 - Hoʻohuli Puʻuwai - nā hopena a me ka hoʻokele olakino
S6-4 - LVAD Koho Hoʻololi a me nā hopena maʻi
S6-5 - LVAD hanana hanana a me ka mālama maʻi
S6-6 - Ka mālama ʻana i nā launa lāʻau
S6-7 - Q&A
S7-2 - Cardiac Resynchronization Therapy - Nā Hana Hou Hou
S7-3 - Arrhythmia Management Antiarrhythmic Drugs a me VT Ablation
S7-4 - Ka hopena o AFIB ma HF
S7-5 - Anticoagulation ʻōnaehana mai VKA a i NOAC
S7-6 - Kāohi ʻana i ka make ʻana o ka Cardiac i ka wā pōkole, nā lole komo a me nā mea hiki ʻole ke kanu ʻia
S7-7 - Q&A
S8-1 - Hoʻoemi i nā heluhelu heluhelu 30 Day
S8-2 - Hoʻololi i nā maʻi ma waho o ka Halemai
S8-3 - Nā papahana no ka mālama ʻana i nā mea maʻi mai ka haukapila
S8-4 - ʻAʻole lākou mākaukau no ka mālama Palliative maoli a laila
S8-5 - Kūkākūkā Kūlana Hihia
S9-1 - Hypertrophic Cardiomyopathies a me ka loiloi no ka make ʻana o ka Cardiac
S9-2 - Amyloidosis Cardiac
S9-3 - Pregnancy a me Peripartum Cardiomyopathy
S9-4 - Cardiomyopathies me ka Myocarditis
S9-5 - Metabolic Challenges Obesity, Diabetes, Anemia
S9-6 - Kūkākūkā me Fareside me ka mea maʻi
S9-7 - Q&A